MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 53 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,799,926 | -26.9% | 1,628,377 | +4.6% | 0.00% | – |
| Q2 2023 | $10,663,998 | -5.4% | 1,556,788 | +7.6% | 0.00% | – |
| Q1 2023 | $11,275,510 | +3.9% | 1,447,434 | +1.5% | 0.00% | – |
| Q4 2022 | $10,857,294 | -5.6% | 1,426,714 | +1.4% | 0.00% | – |
| Q3 2022 | $11,501,000 | -47.4% | 1,407,667 | -37.8% | 0.00% | -100.0% |
| Q2 2022 | $21,882,000 | -48.0% | 2,262,906 | -24.6% | 0.00% | 0.0% |
| Q1 2022 | $42,098,000 | +90.8% | 3,002,772 | +177.9% | 0.00% | 0.0% |
| Q4 2021 | $22,066,000 | -2.9% | 1,080,616 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $22,726,000 | +901.1% | 1,020,021 | +920.0% | 0.00% | – |
| Q2 2021 | $2,270,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $10,085,467 | 4.94% |
| NEA Management Company, LLC | 7,692,298 | $52,692,241 | 4.02% |
| Alphabet Inc. | 1,464,015 | $10,028,502 | 0.54% |
| Avoro Capital Advisors LLC | 4,535,000 | $31,064,750 | 0.42% |
| Casdin Capital, LLC | 510,882 | $3,499,542 | 0.31% |
| Baker Brothers Advisors | 3,023,951 | $20,714,064 | 0.12% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $213,419 | 0.07% |
| ExodusPoint Capital Management, LP | 669,495 | $4,586 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $193,115 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 100,478 | $688,274 | 0.02% |